Dry Needling in Multiple Sclerosis
Part of paid clinical trials in Kansas City, Kansas.
- Sponsor
- University of Kansas Medical Center
- Study ID
- NCT06394310
- Status
- Recruiting
Conditions
- Multiple Sclerosis
- Spasticity
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 64 Years
- Healthy Volunteers
- Not accepted
Interventions
- Dry needling — DEVICEThe dry needling technique will employ in the current proposed study follows the standard technique for needling patients with spasticity
- Sham dry needling — DEVICEIn the control group, The investigators will use the methods proposed by Cushman et al. to apply sham dry needling (DN) to our participants
Study Details
The investigators are doing this study to see if a treatment called dry needling improves muscle spasticity (muscle tightness) in people who have Multiple Sclerosis. Dry needling involves using tiny needles, like those in acupuncture, to target some muscles, like calf muscles. It differs from traditional acupuncture as it focuses on treating or managing muscle spots, aiming to reduce muscle stiffness and pain. Dry needling may offer a minimally-invasive and medication-free approach to improve muscle spasticity. The investigators hope to see if dry needling also helps enhance balance and walking abilities. This might provide potential improvements inoverall mobility and balance.
Key Dates
- Start date
- May 1, 2024
- Status verified
- Jun 2025
- Primary completion
- Jul 2, 2025
- Completion
- Aug 1, 2025
Study Design
- Enrollment
- 24 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Dry needlingParticipants will complete three sessions of dry needling through three weeks (one session per each week)
- Sham Comparator: Sham DNParticipants randomized to the control group will be receiving sham needling
Primary Outcome Measure
Spasticity [ Time Frame: 5 weeks ]
Central Contacts
- Abbas TABATABAEI, PhD913-588-3715
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mobility and Falls Lab | Kansas City | Kansas | 66103 |
Find similar trials in Kansas City, KS
Related Studies
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVOPHASE1 · Recruiting · National Cancer Institute (NCI) · Birmingham, Alabama
- User-friendliness of a Portable Driving SimulatorRecruiting · University of Kansas Medical Center · Kansas City, Kansas
- A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity.PHASE1/PHASE2 · Recruiting · Ipsen · Downey, California
- A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)PHASE1 · Recruiting · Juno Therapeutics, Inc., a Bristol-Myers Squibb Company · Birmingham, Alabama